Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Viral

Explore clinical trials studying Skin Diseases, Viral. Study availability and eligibility vary by location and protocol.

353 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Viral trial results

Completed

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

NCT00002181

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Mem Med Group Inc Long Beach, California, United States
  • AIDS Healthcare Foundation Labs Los Angeles, California, United States
  • Sharp Mission Park / Med Group Oceanside, California, United States
  • Park Ctr for Health / Keith Vrhel San Diego, California, United States
View all 15 locations
View Trial Details
Completed

A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients

NCT00002084

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Anus Diseases, +32 more
Locations
  • Univ of South Alabama Mobile, Alabama, United States
  • Univ of Arizona / Health Science Ctr Tucson, Arizona, United States
  • Combat Group Los Angeles, California, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

NCT05683457

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +8 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

NCT06866574

Conditions
Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
Locations
  • Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
  • Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
  • Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
  • Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

NCT06465914

Conditions
AIN1, AIN2, AIN3, +45 more
Locations
  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning, Guangxi, China
  • Hunan Center for Disease Control and Prevention Changsha, Hunan, China
  • Shanxi Provincial Disease for Control and Prevention Taiyuan, Shanxi, China
  • Sichuan Center for Disease Control and Prevention Chengdu, Sichuan, China
View Trial Details

Related conditions